Mini Oral session 1
Q&A and live discussion
Date
11 Dec 2020Session
Mini Oral session 1Presenters
All SpeakersAuthors
A. SpeakersAuthor affiliations
- /US
Resources
Resources from the same session
24MO - Randomized, multicenter, open-label trial of autologous cytokine-induced killer cell immunotherapy plus chemotherapy for squamous non-small cell lung cancer
Presenter: Ren Xiubao
Session: Mini Oral session 1
Resources:
Abstract
Slides
Webcast
62MO - A randomised, controlled, multicenter phase II trial of camrelizumab combined with albumin-bound paclitaxel and cisplatin as neoadjuvant treatment in locally advanced NSCLC
Presenter: Jie Lei
Session: Mini Oral session 1
Resources:
Abstract
Slides
Invited Discussant 24MO
Presenter: Andrew Furness
Session: Mini Oral session 1
Resources:
Slides
Webcast
Invited Discussant 62MO
Presenter: Benjamin Besse
Session: Mini Oral session 1
Resources:
Slides
Webcast